Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pelvic Exenteration as a Curative Option in Recurrent Gynecological Cancer: Oncological Outcomes and Impact on Quality of Life and Sexuality

NCT07594327 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.

NCT NCT07594327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07594327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pelvic Exenteration as a Curative Option in Recurrent Gynecological Cancer: Oncological Outcomes and Impact on Quality of Life and Sexuality
Lead sponsor
Tampere University Hospital
Phase
Observational
Overall status
Enrolling by invitation
Start date
May 31, 2026
Completion date
October 31, 2026
Enrollment
21 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancers, endometrial cancer, gynecologic cancers, vaginal cancers, vulvar cancers